Osaic Holdings
TELO icon

Osaic Holdings’s Telomir Pharmaceuticals TELO Stock Holding History

Osaic Holdings’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.1K Buy
41,490
+5,695
+16% +$7.42K ﹤0.01% 5444
2026
Q1 		$46.5K Buy
35,795
+2,000
+6% +$2.55K ﹤0.01% 5283
2025
Q4 		$44.9K Buy
33,795
+9,285
+38% +$13.4K ﹤0.01% 5301
2025
Q3 		$32.5K Buy
24,510
+3,550
+17% +$5.35K ﹤0.01% 5594
2025
Q2 		$26.2K Buy
20,960
+4,880
+30% +$11.3K ﹤0.01% 5508
2025
Q1 		$51.9K Buy
16,080
+9,797
+156% +$42.8K ﹤0.01% 4690
2024
Q4 		$25.9K Buy
6,283
+4,305
+218% +$20.3K ﹤0.01% 5167
2024
Q3 		$12.7K Buy
1,978
+978
+98% +$4.77K ﹤0.01% 5666
2024
Q2 		$4.81K Buy
1,000
+400
+67% +$2.5K ﹤0.01% 6194
2024
Q1 		$3.09K Buy
+600
New +$4.53K ﹤0.01% 6303

Other funds holding TELO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.04B AUM 22.7% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return

Osaic Holdings's TELO Position: Q2 2026 in Review

Osaic Holdings increased its Telomir Pharmaceuticals (TELO) stake by 16% in Q2 2026, buying an estimated $7.42K and bringing the position to 41,490 shares worth $53.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5444.

Osaic Holdings first reported a position in TELO in Q1 2024 and has held it in 10 quarters since. 33 funds tracked by Wall St. Rank hold TELO as of Q2 2026.

  • Osaic Holdings held 41,490 shares of Telomir Pharmaceuticals worth $53.1K as of Q2 2026.
  • Osaic Holdings bought 5,695 Telomir Pharmaceuticals shares in Q2 2026, an estimated $7.42K.
  • Telomir Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5444 holding.
  • Osaic Holdings first reported a position in Telomir Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 33 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.